Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mycelia is a specialized biotechnology company focused on the research, development, and production of high-quality mushroom spawn and fungal cultures. Based in Belgium, the company operates one of the most advanced fungal laboratories in Europe, providing essential biological starting materials for the global mushroom industry. Beyond commercial production, Mycelia offers extensive consultancy services, technical training, and research support for fungal-based applications in agriculture and environmental science. Their expertise spans a wide variety of species, supporting both culinary production and the emerging field of fungal-derived materials and therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mycelia.